BioStem Technologies (BSEM) vs Hyperion DeFi (HYPD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
BioStem Technologies (BSEM) has outperformed Hyperion DeFi (HYPD) over the past year, losing 45.0% versus a loss of 62.9%. Over five years, BSEM leads with a +88.6% price change compared with -99.2% for HYPD. Hyperion DeFi is the larger company by market cap ($51.2 million vs $49.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSEM | HYPD |
|---|---|---|
| Share price | $2.64 | $3.37 |
| Market cap | $49.29M | $51.16M |
| 1-day change | +10.46% | -6.27% |
| YTD return | -30.71% | -5.48% |
| 1-year return | -45.00% | -62.86% |
| 5-year return | +88.57% | -99.21% |
| P/E ratio (TTM) | 3.00 | — |
| Forward P/E | 9.10 | — |
| EPS (TTM) | $0.88 | $-6.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.40 | $9.50 |
| 52-week low | $2.25 | $2.34 |
| Distance from 52-week high | -68.57% | -64.58% |
| Analyst consensus | none | none |
| Avg. price target upside | +165.15% | +192.12% |
| Average volume | 124.14K | 445.34K |
| Shares outstanding | 18.67M | 15.20M |
| Employees | 73 | 9 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BSEM has outperformed HYPD by 17.9 percentage points over the past year.
About BioStem Technologies
BSEM stock →BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States.
Healthcare · Biotechnology · 73 employees
About Hyperion DeFi
HYPD stock →Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets.
Healthcare · Biotechnology · 9 employees
BSEM vs HYPD FAQ
Which is bigger, BioStem Technologies or Hyperion DeFi?
Hyperion DeFi (HYPD) is larger, with a market capitalization of $51.16M compared with $49.29M for BioStem Technologies (BSEM).
Which stock has performed better over the past year, BSEM or HYPD?
BSEM returned -45.00% over the past 12 months, compared with -62.86% for HYPD (price return, excluding dividends). Past performance does not predict future results.
Are BioStem Technologies and Hyperion DeFi in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.